Fresenius Medical Ownership
| FMEA Stock | EUR 22.80 0.40 1.72% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Fresenius |
Fresenius Stock Ownership Analysis
The company has price-to-book (P/B) ratio of 0.58. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fresenius Medical Care has Price/Earnings To Growth (PEG) ratio of 1.06. The entity last dividend was issued on the 13th of May 2022. The firm had 2:1 split on the 4th of December 2012. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. FRESENIUS is traded on Frankfurt Stock Exchange in Germany. To learn more about Fresenius Medical Care call Helen Giza at 49 6172 608 2522 or check out https://www.freseniusmedicalcare.com.Fresenius Medical Outstanding Bonds
Fresenius Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Fresenius Medical Care uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Fresenius bonds can be classified according to their maturity, which is the date when Fresenius Medical Care has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| FRESLN 425 02 OCT 50 Corp BondUS358070AB61 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| FMEGR 375 15 JUN 29 Corp BondUS35805BAA61 | View |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Fresenius Stock
When determining whether Fresenius Medical Care is a strong investment it is important to analyze Fresenius Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fresenius Medical's future performance. For an informed investment choice regarding Fresenius Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.